Endo Pharmaceuticals, Inc.


Recent News About Endo Pharmaceuticals, Inc. View More

ENDO PHARMACEUTICALS, INC.: PGA Golfer Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Parents to Get Their Own Check-Ups This Back-to-School Season

Fresh off a successful summer of tournament play, four-time PGA TOUR winner Tim Herronis once again teaming up with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), on Facts on Hand, an educational campaign to raise awareness of Dupuytren's Contracture, a common yet often misunderstood hand condition.

ENDO PHARMACEUTICALS, INC.: Endo Announces Appointment of Laure Park as Senior Vice President, Investor Relations and Corporate Affairs

Endo International plc (NASDAQ: ENDP) announced today that it has appointed Laure Park as Senior Vice President, Investor Relations and Corporate Affairs, effective immediately.

ENDO PHARMACEUTICALS, INC.: Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, LLC(collectively, "Endo" or the "Company") have executed a definitive master settlement agreement (the "Agreement") allowing for the resolution of all known testosterone replacement therapy product liability claims against the Company.


Endo Pharmaceuticals, Inc. Upcoming Events View More

No Events

Metro Business Network